There are 2867 resources available
Invited Discussant LBA10 and LBA11
Presenter: Natasha Leighl
Session: Presidential Symposium III
Resources:
Slides
Webcast
Invited Discussant 1644O and 1645O
Presenter: Marcia Brose
Session: Proffered Paper session: NETs and endocrine tumours
Resources:
Slides
Webcast
459MO - Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation
Presenter: Manish Patel
Session: Mini Oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1318MO - Time to diagnosis among patients with cancer in the US
Presenter: Matthew Gitlin
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: NETs and endocrine tumours
Resources:
Slides
Webcast
460MO - Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers
Presenter: Komal Jhaveri
Session: Mini Oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Invited Discussant 1321MO, 1322MO and 1318MO
Presenter: Felipe Roitberg
Session: Mini Oral session: Policy and preventive strategies
Resources:
Slides
Webcast
Invited Discussant 459MO and 460MO
Presenter: Myung-Ju Ahn
Session: Mini Oral session: Developmental therapeutics
Resources:
Slides
Webcast
Welcome and Introduction
Presenter: Andrea Necchi
Session: Bristol Myers Squibb - Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape
Resources:
Webcast